BioCentury | Jan 28, 2010
Distillery Therapeutics

Indication: Cancer

...cancer Cyclin-dependent kinase 4 (CDK4); microRNA-26a (miR-26a) A study in mice and in humans suggests that miR-26a...
...biomarker for aggressive cases of glioblastoma multiforme (GBM). Mice that received human GBM cells overexpressing miR-26a...
...significantly larger tumors than mice given mock-transfected cells (p<0.009). In GBM patients, higher levels of miR-26a...
BioCentury | Jul 9, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Hepatocellular carcinoma (HCC) MicroRNA-26 (miRNA-26a) Studies in cell culture and in mice suggest that delivering miRNA-26a to the liver could help treat HCC. In human...
BioCentury | Jul 9, 2009
Targets & Mechanisms

Tumor-suppressing miRNAs

...advantages," he said. "Sustained expression of miRNA is possible with a single delivery of the miR-26a...
BioCentury | Jun 18, 2009
Distillery Therapeutics

Indication: Cancer

...Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Brain cancer MicroRNA-26a (miRNA-26a); phosphatase...
BioCentury | Sep 11, 2008
Distillery Therapeutics

This Week in Therapeutics

...contact information Cancer Lymphoma Cellular myelocytomatosis oncogene (c-MYC); enhancer of zeste homolog 2 (Drosophila) (EZH2); MicroRNA-26a...
Items per page:
1 - 5 of 5